Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The British Journal of Dermatology|March 28, 2017
Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of MalaysiaH Y Chong, Z Mohamed, L L Tan, et al.
International Journal of Obesity (2005)|May 27, 2005
Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE studyS G Terra, S P McGorray, R Wu, et al.
The Pharmacogenomics Journal|September 11, 2013
Ethnicity-specific pharmacogenetics: the case of warfarin in African AmericansW Hernandez, E R Gamazon, K Aquino-Michaels, et al.
The Pharmacogenomics Journal|August 10, 2016
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithmsK Kubo, M Ohara, M Tachikawa, et al.
Clinical Pharmacology and Therapeutics|March 5, 2010
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora, D C Koboldt, C R King, et al.
Clinical Pharmacology and Therapeutics|February 16, 2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 UpdateJ A Johnson, K E Caudle, L Gong, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Pageof 2